{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:25:49Z","timestamp":1791120349581,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1124\/jpet.111.188441","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T02:52:41Z","timestamp":1320115961000},"page":"350-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis"],"prefix":"10.1016","volume":"340","author":[{"given":"Greg","family":"Coffey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"DeGuzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhong J.","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Hollenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.188441_bib1","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0024-3205(98)00538-4","article-title":"Janus kinases and their role in growth and disease","volume":"64","author":"Aringer","year":"1999","journal-title":"Life Sci"},{"key":"10.1124\/jpet.111.188441_bib2","doi-asserted-by":"crossref","first-page":"55827","DOI":"10.1074\/jbc.M409792200","article-title":"A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase","volume":"279","author":"Atwell","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.188441_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/ni.1955","article-title":"A genetically selective inhibitor demonstrates a function for the kinase Zap70 in regulatory T cells independent of its catalytic activity","volume":"11","author":"Au-Yeung","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.111.188441_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/abio.2001.5027","article-title":"Detection of insulin receptor tyrosine kinase activity using time-resolved fluorescence energy transfer technology","volume":"291","author":"Biazzo-Ashnault","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.111.188441_bib5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1181928","article-title":"Platelets amplify inflammation in arthritis via collagen-dependent microparticle production","volume":"327","author":"Boilard","year":"2010","journal-title":"Science"},{"key":"10.1124\/jpet.111.188441_bib6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.188441_bib7","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1182\/blood-2009-07-233692","article-title":"Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia","volume":"115","author":"Buchner","year":"2010","journal-title":"Blood"},{"key":"10.1124\/jpet.111.188441_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/378303a0","article-title":"Syk tyrosine kinase required for mouse viability and B-cell development","volume":"378","author":"Cheng","year":"1995","journal-title":"Nature"},{"key":"10.1124\/jpet.111.188441_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1358.002","article-title":"B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens","volume":"1062","author":"Chiorazzi","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/jpet.111.188441_bib10","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.1727.1727","article-title":"Specific inhibition of Syk suppresses leukocyte immune function and alleviates inflammation in rodent models of rheumatoid arthritis","volume":"116","author":"Coffey","year":"2010","journal-title":"Blood"},{"key":"10.1124\/jpet.111.188441_bib11","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor \u03baB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.111.188441_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1124\/jpet.111.188441_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2005.11.001","article-title":"ITAM-based signaling beyond the adaptive immune response","volume":"104","author":"Fodor","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1124\/jpet.111.188441_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2172-8-31","article-title":"Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo","volume":"8","author":"Frommhold","year":"2007","journal-title":"BMC Immunol"},{"key":"10.1124\/jpet.111.188441_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1034\/j.1600-065x.2001.1840117.x","article-title":"Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis","volume":"184","author":"Holmdahl","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1124\/jpet.111.188441_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jim.2009.01.009","article-title":"Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies","volume":"343","author":"Hutamekalin","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1124\/jpet.111.188441_bib17","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/art.27438","article-title":"Genetic deficiency of Syk protects mice from autoantibody-induced arthritis","volume":"62","author":"Jakus","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.111.188441_bib18","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/art.24567","article-title":"The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo","volume":"60","author":"Kremer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.111.188441_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0030-5898(20)31137-8","article-title":"Biochemical and metabolic aspects of osteoarthritis","volume":"2","author":"Mankin","year":"1971","journal-title":"Orthop Clin North Am"},{"key":"10.1124\/jpet.111.188441_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"M\u00f3csai","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.111.188441_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(02)00303-5","article-title":"Syk is required for integrin signaling in neutrophils","volume":"16","author":"M\u00f3csai","year":"2002","journal-title":"Immunity"},{"key":"10.1124\/jpet.111.188441_bib22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"key":"10.1124\/jpet.111.188441_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1124\/jpet.111.188441_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clim.2007.03.543","article-title":"Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor","volume":"124","author":"Pine","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1124\/jpet.111.188441_bib25","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/emboj\/16.9.2333","article-title":"The Fc receptor \u03b3-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen","volume":"16","author":"Poole","year":"1997","journal-title":"EMBO J"},{"key":"10.1124\/jpet.111.188441_bib26","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","article-title":"B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406","volume":"114","author":"Quiroga","year":"2009","journal-title":"Blood"},{"key":"10.1124\/jpet.111.188441_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v012.i05","article-title":"Bioassay analysis using R","volume":"12","author":"Ritz","year":"2005","journal-title":"J Stat Software"},{"key":"10.1124\/jpet.111.188441_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.immuni.2005.03.004","article-title":"Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins","volume":"22","author":"Rogers","year":"2005","journal-title":"Immunity"},{"key":"10.1124\/jpet.111.188441_bib29","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.148.7.2103","article-title":"Induction of arthritis with monoclonal antibodies to collagen","volume":"148","author":"Terato","year":"1992","journal-title":"J Immunol"},{"key":"10.1124\/jpet.111.188441_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.146.3.857","article-title":"Autoimmunity to type II collagen an experimental model of arthritis","volume":"146","author":"Trentham","year":"1977","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.111.188441_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/378298a0","article-title":"Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk","volume":"378","author":"Turner","year":"1995","journal-title":"Nature"},{"key":"10.1124\/jpet.111.188441_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-5699(99)01574-1","article-title":"Tyrosine kinase SYK: essential functions for immunoreceptor signalling","volume":"21","author":"Turner","year":"2000","journal-title":"Immunol Today"},{"key":"10.1124\/jpet.111.188441_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CCO.0b013e328011a25f","article-title":"Ba\/F3 cells and their use in kinase drug discovery","volume":"19","author":"Warmuth","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1124\/jpet.111.188441_bib34","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/art.23992","article-title":"Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial","volume":"58","author":"Weinblatt","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.111.188441_bib35","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1084\/jem.20072660","article-title":"PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR\u03b3 to induce slow leukocyte rolling","volume":"205","author":"Zarbock","year":"2008","journal-title":"J Exp Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.188441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:41:50Z","timestamp":1740019310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524467256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0022356524467256"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.188441","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.188441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}